Connor, Clark & Lunn Investment Management (CC&L)’s Organogenesis Holdings ORGO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
593,233
-74,296
| -11% | -$272K | 0.01% | 831 |
|
|
2025
Q1 | $2.88M | Buy |
667,529
+208,038
| +45% | +$899K | 0.01% | 635 |
|
|
2024
Q4 | $1.47M | Sell |
459,491
-11,749
| -2% | -$37.6K | 0.01% | 816 |
|
|
2024
Q3 | $1.35M | Buy |
471,240
+24,878
| +6% | +$71.2K | 0.01% | 787 |
|
|
2024
Q2 | $1.25M | Buy |
446,362
+19,158
| +4% | +$53.6K | 0.01% | 797 |
|
|
2024
Q1 | $1.21M | Buy |
427,204
+62,676
| +17% | +$178K | 0.01% | 827 |
|
|
2023
Q4 | $1.49M | Buy |
364,528
+51,298
| +16% | +$210K | 0.01% | 744 |
|
|
2023
Q3 | $996K | Sell |
313,230
-82,280
| -21% | -$262K | 0.01% | 821 |
|
|
2023
Q2 | $1.31M | Buy |
395,510
+102,198
| +35% | +$339K | 0.01% | 715 |
|
|
2023
Q1 | $625K | Buy |
293,312
+251,789
| +606% | +$536K | ﹤0.01% | 825 |
|
|
2022
Q4 | $112K | Buy |
+41,523
| New | +$112K | ﹤0.01% | 1104 |
|